[Letter concerning the article by E.C.Bornhövd, E.Schuller, T.Bieber, A.Wollenberg: "Immunosuppressive macrolides and their use in dermatology". Der Hautarzt (2000) 51:646-654].
Krisp
A
A
Hoffmann
R
R
D001628:Beverages; D002121:Calcium Channel Blockers / Q000097:blood / Q000493:pharmacokinetics; D002957:Citrus / Q000378:metabolism*; D016572:Cyclosporine / Q000493:pharmacokinetics; D004064:Digestive System / Q000378:metabolism; D004347:Drug Interactions; D015736:Felodipine / Q000097:blood / Q000493:pharmacokinetics; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics*; D008099:Liver / Q000378:metabolism; D012871:Skin Diseases / Q000188:drug therapy*; D016559:Tacrolimus / Q000493:pharmacokinetics; D015262:Xenobiotics / Q000378:metabolism
D002121:Calcium Channel Blockers; D007166:Immunosuppressive Agents; D015262:Xenobiotics; D016572:Cyclosporine; D015736:Felodipine; D016559:Tacrolimus